Global companies expand the reach of their cancer drugs in China

Stat News

10 March 2020 - While much of the world is understandably focused on the new coronavirus’s emergence in China, three recent developments involve the potential expansion of treatments for an entrenched disease there: cancer.

One biotech is making it easier for patients to keep taking its checkpoint inhibitor, one pharma giant has won approval for a new type of cancer its targeted drug therapy can treat, and another major pharma has won the go-ahead for a combination therapy.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , Market access , China